CLINICAL RESEARCH: BRACHIAL FLOW-MEDIATED DILATION AND ATHEROSCLEROSIS
Relationship Between Carotid Artery Intima-Media Thickness and Brachial Artery Flow-Mediated Dilation in Middle-Aged Healthy Men
Raymond T. Yan, MD, MASc*,
Todd J. Anderson, MD, FRCPC, FACC ,
Francois Charbonneau, MD, MSc, FRCPC, FACC ,
Lawrence Title, MD, FRCPC, FACC ,
Subodh Verma, MD, PhD ,
Eva Lonn, MD, MSc, FRCPC, FACC*,* on behalf of the FATE Investigators
* Department of Medicine, Division of Cardiology, McMaster University, Hamilton, Canada
Department of Medicine, Division of Cardiology, University of Calgary, Calgary, Canada
Department of Medicine, Division of Cardiology, University of Dalhousie, Halifax, Canada
Division of Cardiovascular Surgery, University of Toronto, Toronto, Canada
Manuscript received October 6, 2004;
revised manuscript received November 16, 2004,
accepted December 6, 2004.
* Reprint requests and correspondence: Dr. Eva Lonn, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada (Email: lonnem{at}mcmaster.ca).
 |
Abstract
|
|---|
OBJECTIVES: We aimed to determine the relationship between carotid intima-media thickness (IMT) and brachial artery flow-mediated dilation (FMD) in healthy middle-age men.
BACKGROUND: Carotid IMT and brachial artery FMD are frequently used as surrogate measures of subclinical atherosclerosis. Whereas carotid IMT identifies early structural abnormalities, brachial artery FMD, considered a bioassay of endothelial function, measures functional vascular integrity. The relationship between carotid IMT and brachial artery FMD has not been well studied.
METHODS: We measured traditional risk factors, carotid IMT, and brachial artery FMD in 1,578 middle-aged men without known cardiovascular disease and analyzed the relationship between carotid IMT and brachial FMD.
RESULTS: Carotid IMT correlated with age, systolic blood pressure, body mass index, fasting glucose, total and low-density lipoprotein (LDL) cholesterol, and with the overall Framingham risk score (p < 0.001 for all), whereas impaired brachial artery FMD correlated with systolic and diastolic blood pressure (p < 0.01). No relationship was observed between carotid IMT and brachial artery FMD for the entire cohort (r = 0.006, p = 0.82) and in subgroups defined by traditional risk factors or by quintiles of carotid IMT and brachial FMD.
CONCLUSIONS: In middle-aged healthy men, there is no significant correlation between carotid IMT and brachial artery FMD. This finding suggests that these are unique, independent surrogates that measure different aspects and stages of early atherosclerosis. Further studies are needed to define their role in clinical research and in cardiovascular risk assessment.
|
Abbreviations and Acronyms
| | BMI = body mass index | | CV = cardiovascular | | CVD = cardiovascular disease | | FATE = Firefighters And Their Endothelium study | | FMD = flow-mediated dilation | | IMT = intima-media thickness | | LDL = low-density lipoprotein | | US = ultrasound |
|
It has been suggested that "atherosclerosis imaging may enhance the detection and treatment of patients at risk for coronary heart disease" (1). Proposed noninvasive atherosclerosis imaging techniques that may improve current risk stratification include carotid ultrasound (US) and brachial artery reactivity testing. High-resolution US measurements of carotid artery intima-media thickness (IMT) identify and quantitate early structural vascular abnormalities (2,3). Increased carotid IMT correlates with cardiovascular (CV) risk factors (46) and is a potent independent predictor of myocardial infarction and stroke (68). Brachial artery flow-mediated dilation (FMD) is an in vivo indicator of vascular endothelial function (2,9,10) and was also shown to correlate with various CV risk factors (911) and to have prognostic significance (1214), albeit in much smaller studies that require further confirmation.
Several previous studies in patients with cardiovascular disease (CVD) or major risk factors have reported inverse correlations between carotid IMT and brachial artery FMD (1519). These studies were small, however (ranging from 20 to 150 study participants), and need to be interpreted with caution. Moreover, the relationship between carotid IMT and brachial artery FMD has not been adequately evaluated in apparently healthy individuals without CVD. This relationship may be particularly relevant in those subjects considered to be at low and intermediate risk of future events based on current risk stratification algorithms, as they are expected to benefit most from early atherosclerosis detection.
The Firefighters And Their Endothelium (FATE) study is an ongoing prospective longitudinal cohort study designed to assess the relationship among endothelial function, emerging and traditional CV risk factors, and, ultimately, clinical events (20). The current report describes the determinants of carotid IMT and brachial artery FMD and examines the correlation between these two measures of subclinical atherosclerosis in the FATE study participants.
 |
Methods
|
|---|
Study design and study population.
The design and objectives of the FATE study have been previously published (20). In summary, this is a prospective cohort study of risk factors and predictors of CV events.
Between March 1999 and October 2003, 1,578 active and retired Canadian firefighters from Calgary and Red Deer, Alberta (n = 834); Toronto and Hamilton, Ontario (n = 403); Montreal, Quebec (n = 251); and Halifax, Nova Scotia (n = 90) were enrolled. All assessments were performed at four research centers (Calgary, Hamilton, Montreal, and Halifax). This cohort was selected as representative of middle-aged men at low to moderate CV risk. Subjects were excluded if they had known vascular disease. The study was approved by the ethics committee of each participating institution, and study participants provided written informed consent. Traditional and emerging CV risk factors were measured, and long-term follow-up is planned. Measurements of carotid IMT and brachial artery FMD were obtained in all study participants. The primary objective of the FATE study is to determine whether the measurement of endothelial function by brachial artery FMD is an independent predictor of CV events in this population. The evaluation of the relationship between carotid IMT and brachial artery FMD was a prespecified study objective.
US methods.
Carotid IMT and brachial artery FMD examinations were performed at the four participating centers, each with an established, experienced research US laboratory, using SONOS 5500 (Andover, Massachusetts) or Acuson/Acoustic Response Technology ART 1 imaging systems (Mountain View, California) equipped with high-resolution 7.5 to 10 MHz linear phase-arrayed vascular transducers (within each center, all US examinations were performed using the same imaging system).
The anatomic extent of subclinical atherosclerosis was measured by quantitative B-mode US of the far wall of the right common carotid artery. All study sonographers underwent standardized training and used a common and extensively validated imaging protocol. Reproducibility and adherence to the imaging protocol were verified for each sonographer. The imaging protocol consisted of identification of the flow divider between the internal and external carotid arteries, followed by a circumferential scan of the far wall of the right common carotid artery, defined as the arterial segment starting 1 cm below the flow divider and extending 1 cm distally. The circumferential scan aimed to identify the region of this arterial segment with the highest IMT. All US examinations were recorded on S-VHS tapes and subsequently digitized and analyzed offline at the Core Carotid US Laboratory in Hamilton by one of three certified readers blinded to all clinical information, using the Image-Pro V4.5.1 software (Glen Burnie, Maryland). The Core Laboratory has extensive experience using this technique, with a high degree of reproducibility and accuracy in previous large epidemiologic studies and clinical trials (21,22). For each study participant, a minimum of three frames of the far wall of the right common carotid artery were digitized and measured. Measurements were done by tracing the leading edge of the lumen-intima and the media-adventitia interfaces, which yielded a segment mean IMT (the average thickness across the 1-cm segment mean carotid IMT) and a segment maximum IMT (the single highest measurement between two opposing points on these interfaces maximum carotid IMT). The frames with the highest measurements were chosen. Repeat measurements were obtained in 80 randomly chosen scans. The within- and between-reader intraclass correlation coefficients for repeat measurements ranged from 0.92 to 0.96 and are similar to previous data from our laboratory and consistent with high measurement reproducibility.
Endothelial function was evaluated by measurements of FMD of the brachial artery in response to hyperemia according to previously described and extensively validated methodology (2,9,23). Participants were free of recent fire exposure or exposure to vasoactive medications. The right brachial artery immediately above the antecubital fossa was imaged using B-mode US, and flow was measured using pulsed-wave Doppler. Simultaneous electrocardiographic recordings were obtained and displayed on the on the US system video monitor. Baseline imaging was followed by 5-min occlusion of arterial flow, achieved by inflation of a pneumatic cuff above the antecubital fossa (upper arm occlusion) to suprasystolic pressures. Following deflation of the pneumatic cuff the brachial artery was imaged continuously for 3 min (reactive hyperemia, endothelium-dependent dilation). A repeat baseline scan was obtained after a 10-min rest. Thereafter, brachial artery flow and diameter changes in response to sublingual nitroglycerin (0.3 mg) were recorded (endothelium-independent dilation). All sites used a common scanning protocol verified by the Core Brachial US Laboratory in Calgary, and all measurements were performed by a single experienced technician at the Core Laboratory. Two sequential diastolic frames (taken at the tip of the R-wave on the electrocardiogram) for the baseline, reactive hyperemia, repeat baseline, and nitroglycerin stages were digitized using an analog-to-digital converting board. Straight segments of the artery (10 mm in length) were chosen. Computer-assisted edge detection brachial analysis software (DEA, Vasometrix, Montreal) was used to calculate brachial artery diameters. The two frames were averaged for each intervention. Endothelium-dependent FMD was defined as the maximal percent change in brachial artery diameter (between 60 and 90 s) after reactive hyperemia compared to baseline. The intraobserver and interobserver variability for repeat measurements at the Core Laboratory are 0 ± 0.07 mm and 0.05 ± 0.16 mm, respectively (24). To document scanning reproducibility, 50 subjects had repeat FMD testing 6 to 12 months after initial evaluation. The group mean was similar on both occasions, 8.2 ± 3.2% versus 8.3 ± 2.8%, and the mean of the absolute difference between determinations for each subject was a very favorable 1.8 ± 1.6%.
Statistical analysis.
Continuous variables are expressed as means ± SD and discrete variables as counts and percentages. Because carotid IMT measurements were not normally distributed, logarithmic transformation was used. Means were compared using analysis of variance or the Student t test. Pearsons correlation was used to test bivariate correlations and results were verified using the nonparametric Spearmans rank correlation test. Multivariate linear regression analysis with backward elimination was used to determine the independent predictors of carotid IMT and of brachial FMD and to test the relationship between carotid IMT and brachial FMD (in this analysis carotid IMT was the dependent variable and brachial FMD was tested as an independent predictor) in models including classic risk factors. The relationship between carotid IMT and brachial FMD was tested for the entire cohort, in subgroups defined by traditional risk factors, and in subsets divided by quintiles of carotid IMT and by quintiles of brachial FMD (within each fifth, Pearsons and Spearmans rank bivariate correlation tests were performed). Statistical significance was defined as two-sided p < 0.05. All statistical analyses were performed using SPSS version 12.0 (SPSS Inc, Chicago, Illinois).
 |
Results
|
|---|
Study population.
Demographic data, CV risk factors, carotid IMT, and brachial FMD measurements are shown in Table 1. By design, the cohort was predominantly male. Participants were commonly overweight. Relatively few study participants reported current smoking or a history of diabetes or hypertension. On average, blood pressure, cholesterol, and fasting plasma glucose levels were within target ranges for primary disease prevention. The average 10-year risk for coronary heart disease calculated according to the Framingham model (25) was 8.2%, consistent with a relatively low-risk population.
The average mean and maximum carotid IMT measurements were 0.72 ± 0.18 mm and 0.73 ± 0.19 mm, respectively, similar to previous published data in similar populations (26). Mean brachial artery FMD was 8.59 ± 4.05%, lower than 10%, which is the generally accepted normal lower range for this test. A significant number of subjects, 1,106 (70.1% of the study population), had attenuated FMD (<10%).
Correlations between traditional cardiovascular risk factors and carotid IMT.
Study participants with a history of hypertension had higher carotid IMT than those without (0.81 ± 0.20 mm vs. 0.70 ± 0.18 mm, p < 0.0001 for mean carotid IMT; and 0.82 ± 0.21 mm vs. 0.72 ± 0.18 mm, p < 0.0001 for maximum carotid IMT), as did those with a history of diabetes compared to those without (0.81 ± 0.22 mm vs. 0.71 ± 0.18 mm, p = 0.001 for mean carotid IMT; and 0.82 ± 0.22 mm vs. 0.73 ± 0.18 mm, p = 0.002 for maximum carotid IMT). Trends toward higher carotid IMT were observed for current smokers versus those who denied current smoking (0.72 ± 0.16 mm vs. 0.71 ± 0.18 mm for mean carotid IMT and 0.74 ± 0.17 mm vs. 0.72 ± 0.19 mm for maximum carotid IMT), although these differences did not reach statistical significance. Bivariate correlations between carotid IMT and measured traditional CV risk factors are summarized in Table 2. Both mean and maximum carotid IMT correlated with age, systolic blood pressure, body mass index, total and LDL cholesterol, and fasting plasma glucose (p < 0.001 for all). Similar results were obtained using nonparametric analyses (data not shown). Importantly, both mean and maximum carotid IMT had highly statistically significant correlations of moderate magnitude with the overall Framingham risk score (r = 0.38, p < 0.001; and r = 0.37, p < 0.001, respectively). In multivariate analyses, both mean and maximum carotid IMT were independently correlated with age and with systolic and diastolic blood pressure, and maximum carotid IMT also correlated with LDL cholesterol concentration.
View this table:
[in this window]
[in a new window]
|
Table 2. Bivariate Correlations (Pearsons Correlation Coefficients) Between Cardiovascular Risk Factors and Ultrasound Measures of Subclinical Atherosclerosis and Endothelial Dysfunction
|
|
Correlations between traditional cardiovascular risk factors and brachial artery FMD.
Brachial artery FMD did not differ significantly among study participants with or without a history of hypertension, diabetes, or current smoking. As shown in Table 2, there was a modest inverse correlation between brachial artery FMD and systolic and diastolic blood pressure in univariate analyses, suggesting that study participants with higher blood pressure had more abnormal endothelial function. However, there were no significant correlations between brachial artery FMD and other measured individual risk factors and the overall Framingham risk score (r = 0.019, p = NS). In multivariate analysis, only higher systolic blood pressure was independently predictive of lower brachial artery FMD (p = 0.001).
Relationship between carotid IMT and brachial artery FMD.
Adequate measurements of both carotid IMT and brachial artery FMD were obtained in 1,557 study participants (98.7%). There was no significant correlation between brachial artery FMD and mean carotid IMT (r = 0.006, p = 0.82) or maximum carotid IMT (r = 0.012, p = 0.65) (Fig. 1). The lack of an overall correlation was consistent in nonparametric correlation analyses (Table 3). Because of the known impact of smoking on brachial artery FMD, these relationships were examined in analyses stratified by smoking status. No significant correlations were found. Subjects with and without abnormal endothelial response, defined as brachial artery FMD <10%, did not differ significantly in their measured mean or maximum carotid IMT (mean carotid IMT: 0.72 ± 0.18 mm vs. 0.71 ± 0.17 mm, p = 0.59; maximum carotid IMT: 0.73 ± 0.18 mm vs. 0.72 ± 0.18 mm, p = 0.58). No significant differences in brachial artery FMD were noted in those subjects with mean and/or maximum carotid IMT below and above the mean or the median value for the entire cohort. In multivariate regression models with mean and maximum carotid IMT, respectively, as dependent variables and brachial artery FMD and other variables identified in bivariate analysis to be significantly correlated with carotid IMT as predictors, brachial artery FMD was not an independent predictor of either mean (beta coefficient = 0.052; p = 0.70) or maximum carotid IMT (beta coefficient = 0.015; p = 0.912).

View larger version (25K):
[in this window]
[in a new window]
|
Figure 1 Correlation between mean carotid intima-media thickness (IMT) and brachial artery flow-mediated dilation (FMD).
|
|
View this table:
[in this window]
[in a new window]
|
Table 3. Relationship Between Carotid IMT and Brachial Artery FMD Across Quintiles of Carotid IMT and Brachial FMD
|
|
The impact of traditional CV risk factors on the relationship between carotid IMT and brachial artery FMD was evaluated in prespecified subgroup analyses. There was no significant correlation between carotid IMT (both mean and maximum IMT) and brachial artery FMD among current smokers or subjects with hypertension (history of hypertension or blood pressure >140/90 mm Hg) or diabetes (history of diabetes or fasting blood glucose >7.0 mmol/l).
We divided the study participants by quintiles of carotid IMT, i.e., in subsets defined by various degrees of structural vascular abnormalities (Table 3), and evaluated the correlation between carotid IMT and brachial artery FMD within each fifth. There were no significant correlations. We then divided the study population by quintiles of brachial artery FMD, i.e., in subsets defined by various degrees of functional vascular abnormalities (Table 3), and evaluated correlations between carotid IMT and brachial artery FMD within each fifth. No significant correlations were observed.
All correlation analyses between carotid IMT and brachial artery FMD were also evaluated in analyses stratified by study center. Results were similar, with lack of correlation between carotid IMT and brachial artery FMD for the entire cohort and within each of the four research centers.
 |
Discussion
|
|---|
The main finding of our study is the lack of correlation between measurements of carotid IMT and brachial artery FMD in a cohort of middle-aged men without CVD and with relatively few risk factors. This finding could have several explanations: 1) it is possible that, contrary to current prevalent beliefs, carotid IMT and/or brachial artery FMD are not valid measures of early vascular disease; 2) it is possible that the research techniques employed, specifically the US measurements, were not adequate and allowed for noise, which may have obscured an existent correlation; and finally, 3) carotid IMT and brachial artery FMD may provide distinct information identifying different stages in atherogenesis. We believe the latter to principally account for our findings, although we cannot exclude the possibility that brachial artery FMD may be less informative in this cohort than previously thought.
Thus, both carotid IMT and brachial artery FMD are well-validated techniques (2,3,9,23). Both are highly reproducible when performed by experienced technicians in a research environment (213,2124). Carotid IMT was shown to correctly identify histologic abnormalities and to correlate with traditional and emerging cardiovascular risk factors (26). It correlates with prevalent CV disease (4,21) and, importantly, it was a potent independent predictor of incident myocardial infarction and of stroke in large cohort studies (68). Moreover, interventions known to decrease the atherosclerotic process and to prevent clinical events, such as statins, angiotensin-converting enzyme inhibitors, and other blood-pressure-lowering agents (2,3,22), were shown to retard the progression of carotid IMT. Several lines of evidence suggest that brachial artery FMD is a valid measure of vascular integrity. The vasomotor response of the brachial artery in response to hyperemia measured by high-resolution US was shown to be nitric-oxide-dependent and to correlate well with coronary endothelial-dependent vasomotor function (9,23,24). Interventions that improve vascular health and increase the bioavailability of nitric oxide, such as statins and angiotensin-converting enzyme inhibitors, were shown to improve brachial artery FMD (9,27,28). Finally, although examined to date only in relatively small studies that are often retrospective and requiring further confirmation, emerging evidence suggests that brachial artery FMD may be an independent predictor of outcomes (1214). It is essential, however, to realize that the data correlating brachial artery FMD to coronary endothelial function and to CV outcomes are derived primarily from studies in individuals with manifest CV disease or at high risk for CV disease, with very limited information on low- and moderate-risk groups.
The notion that technical limitations in performing the US assessments may have obscured an existent correlation is not justified. Indeed, all US scans were performed at experienced research US laboratories, following common standardized protocols and using rigorous quality control measures; all measurements were obtained at the Core US Laboratories, which have extensive experience with these techniques. Scanning and measurement reproducibility were high. Moreover, analysis of the correlation between carotid IMT and brachial artery FMD within each center and for the entire cohort stratified by study center yielded similar results.
Therefore, we believe that our findings support the conclusion that in apparently healthy individuals with relatively few risk factors, carotid IMT and brachial artery FMD do indeed provide distinct, independent information about the complex atherosclerotic process. Such information may be temporarily dissociated, with abnormalities in endothelial function preceding anatomic lesion formation. However, we do recognize the possibility that brachial artery FMD, which is less well validated in prospective studies than carotid IMT and did not correlate with classic risk factors in our study, may be of limited value in a relatively healthy population, which, in the absence of major sustained alterations to vascular function imposed by the prolonged exposure to traditional risk factors, may be more susceptible to the impact of short-term (possibly transient) factors. Several previous small studies (some lacking methodologic details) have evaluated this relationship and do generally report significant correlations (1519). We believe that a strong publication bias may have resulted in underreporting of negative studies. Moreover, with few exceptions (16), previous studies have focused on high-risk patients.
We also report associations between traditional CV risk factors and carotid IMT and brachial artery FMD, respectively. In univariate analysis, carotid IMT correlated with age, systolic blood pressure, body weight and body mass index, total and LDL cholesterol, fasting blood glucose, and a history of hypertension and of diabetes. Importantly, there was a significant correlation of moderate magnitude with the overall Framingham risk score. In multivariate analysis, age, blood pressure, and LDL cholesterol concentration were independent predictors of carotid IMT. Our observations are consistent with previous reports (27). Some risk factors appear only modestly correlated with carotid IMT, which may be related to overall good risk factor control in our population and the data for carotid IMT and for many risk factors clustering around average ("normal") population values.
By contradistinction, brachial artery FMD was correlated only with blood pressure. The poor correlation between brachial artery FMD and traditional risk factors is puzzling and may reflect the complexity of endothelial function, which is the result of the interplay of a wide range of systemic factors, including those acting for years or decades (CV risk factors), but also acute influences. Previous studies relating brachial FMD and risk factors have yielded mixed results and have suffered from small sample sizes, different methodologies, and heterogeneous populations. In one of the larger previous studies, Celermajer et al. (11) assessed brachial artery FMD in 500 healthy subjects. In multivariate analysis, the strongest determinants were age and cigarette smoking. However, no relationship between lipid parameters or blood pressure and brachial artery FMD was found. In a population of young adults (n = 326), Leeson et al. (29) demonstrated a weak relationship between n-3 fatty acids and FMD in certain subgroups, but no relationship with standard risk factors. In our study, a weak relationship between FMD and blood pressure is identified. However, there was no correlation with age, other risk factors, or Framingham risk scores. These findings suggest that brachial artery FMD could represent a unique measure of vascular health, which may be influenced significantly by parameters currently not measured. Such parameters may overwhelm the influences of traditional risk factors, especially in a generally healthy population with a low prevalence of traditional risk factors.
Our findings pertain solely to the population studied, middle-aged, apparently healthy men without CVD, and should not be generalized. Further studies in various populations are needed.
In conclusion, in a relatively healthy cohort of middle-aged men, no significant correlation exists between carotid IMT and brachial artery FMD. This finding may be related to a temporal dissociation between functional and structural vascular abnormalities in a low-risk population. However, we cannot exclude the possibility that brachial artery FMD, which did not correlate with most traditional CV risk factors in our study, may not be a good measure of the sustained effect of risk factors on endothelial function in a low-risk population and may register primarily the short-term impact of various factors. Although these noninvasive measures of early structural subclinical atherosclerosis and of endothelial dysfunction may provide unique and possibly complementary information about vascular health, our findings suggest that endothelial function testing is not yet ready for "prime time" clinical use and underscore the need for well-designed large prospective studies aimed at evaluating the value of brachial artery FMD in predicting CV events. Such studies are underway (20) and may represent the ultimate test of validity for this bioassay of endothelial function.
 |
Footnotes
|
|---|
Supported by grants from the Canadian Institute of Health Research, the Heart and Stroke Foundation of Canada, and Pfizer Canada.
 |
References
|
|---|
1. Taylor AJ, Merz CNB, Udelson JE. Executive summarycan atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J Am Coll Cardiol 2003;41:1860-1862.[Free Full Text]
2. Redberg RF, Vogel RA, Criqui MH, Herrington DM, Lima JAC, Roman MJ. 34th Bethesda Conference Task Force #3what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?. J Am Coll Cardiol 2003;41:1886-1898.[Free Full Text]
3. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thicknessa new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159-169.[CrossRef][Web of Science][Medline]
4. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factorsthe Atherosclerosis Risk In Communities (ARIC) study, 19871993. Am J Epidemiol 1997;146:483-494.[Abstract/Free Full Text]
5. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age. The Muscatine Study Circulation 2001;104:2815-2819.[Abstract/Free Full Text]
6. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease Arterioscler Thromb 1991;11:1245-1249.[Abstract/Free Full Text]
7. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarctionthe Rotterdam Study. Circulation 1997;96:1432-1437.[Abstract/Free Full Text]
8. OLeary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson Jr. SK. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in elderly adults N Engl J Med 1999;340:14-22.[Abstract/Free Full Text]
9. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery J Am Coll Cardiol 2002;39:257-265.[Abstract/Free Full Text]
10. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of early endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 1992;340:1430-1432.[CrossRef][Web of Science][Medline]
11. Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction J Am Coll Cardiol 1994;24:1468-1474.[Abstract]
12. Gokce N, Keaney JF, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function A prospective study Circulation 2002;105:1567-1572.[Abstract/Free Full Text]
13. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease J Am Coll Cardiol 2003;42:1037-1043.[Abstract/Free Full Text]
14. Mancini GB. Vascular structure versus functionis endothelial dysfunction of independent prognostic importance or not?. J Am Coll Cardiol 2004;43:624-628.[Free Full Text]
15. Enderle MD, Schroeder S, Ossen R, et al. Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease Heart 1998;80:349-354.[Abstract/Free Full Text]
16. Hashimoto M, Eto M, Akishita M, Kozaki K, et al. Correlation between flow-mediated vasodilation of the brachial artery and intima-media thickness in the carotid artery in men Arterioscler Thromb Vasc Biol 1999;19:2795-2800.[Abstract/Free Full Text]
17. Furumoto T, Fuji S, Saito N, Mikami T, Kitabatake A. Relationship between brachial artery flow mediated dilation and carotid artery intima-media thickness in patients with suspected coronary artery disease Jpn Heart J 2002;43:117-125.[CrossRef][Medline]
18. Haraki T, Takegoshi T, Kitoh C, et al. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilation in asymptomatic Japanese male subjects amongst apolipoprotein E phenotypes J Intern Med 2002;252:114-120.[CrossRef][Web of Science][Medline]
19. Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K. Interrelationship between non-invasive measurements of atherosclerosisflow-mediated dilation of the brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 2004;173:13-18.[CrossRef][Web of Science][Medline]
20. Anderson TJ, Roberts AC, Hildebrand K, et al. The fate of endothelial function testingrationale and design of the Firefighters And Their Endothelium (FATE) study. Can J Cardiol 2003;19:61-66.[Web of Science][Medline]
21. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canadathe Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-284.[CrossRef][Web of Science][Medline]
22. Lonn E, Yusuf S, Dzavik V, et al. SECURE Investigators Effects of ramipril and vitamin E on atherosclerosisthe study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001;103:919-925.[Abstract/Free Full Text]
23. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans J Am Coll Cardiol 1999;34:631-638.[Free Full Text]
24. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations J Am Coll Cardiol 1995;26:1235-1241.[Abstract]
25. Wilson PW, DAgostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories Circulation 1998;97:1837-1847.[Abstract/Free Full Text]
26. Howard G, Sharett AR, Heiss G, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound ARIC Investigators Stroke 1993;24:1297-1304.[Abstract/Free Full Text]
27. Beckman JA, Liao JK, Hurley S, et al. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein Circ Res 2004;95:217-223.[Abstract/Free Full Text]
28. Anderson TJ, Elstein E, Haber H, et al. Comparative study of ACE inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary artery disease J Am Coll Cardiol 2000;35:60-66.[Abstract/Free Full Text]
29. Leeson P, Thorne S, Donald A, et al. Non-invasive measurement of endothelial functioneffect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 1997;78:22-27.[Abstract/Free Full Text]
Related Article
-
Primary and a Half Prevention: Can We Identify Asymptomatic Subjects With High Vascular Risk?
- David S. Celermajer
J. Am. Coll. Cardiol. 2005 45: 1994-1996.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
W. Sturm, A. Tschoner, J. Engl, S. Kaser, M. Laimer, C. Ciardi, A. Klaus, H. Weiss, A. Sandhofer, J. R. Patsch, et al.
Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis
Eur. Heart J.,
August 2, 2009;
30(16):
2038 - 2043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Jax and T. Lauer
The Art of Primary Prevention and Risk Assessment: Homocysteine Revisited
Stroke,
March 1, 2009;
40(3):
670 - 671.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M Title, E. Lonn, F. Charbonneau, M. Fung, K. J Mather, S. Verma, and T. J Anderson
Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome
Vascular Medicine,
November 1, 2008;
13(4):
263 - 270.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Moro, C. Pedone, S. Scarlata, V. Malafarina, F. Fimognari, and R. Antonelli-Incalzi
Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease
Angiology,
July 1, 2008;
59(3):
357 - 364.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Sen, M. Demirturk, N. Abaci, E. Golcuk, H. Oflaz, A. Elitok, F. Kutluturk, H. Issever, N. E. Unaltuna, and N. C. Ozbey
Endothelial nitric oxide synthase intron 4a/b polymorphism and early atherosclerotic changes in hypopituitary GH-deficient adult patients
Eur. J. Endocrinol.,
May 1, 2008;
158(5):
615 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mattsson, T. Ronnemaa, M. Juonala, J. S.A. Viikari, E. Jokinen, N. Hutri-Kahonen, M. Kahonen, T. Laitinen, and O. T. Raitakari
Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study
Eur. Heart J.,
March 2, 2008;
29(6):
784 - 791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K-K Lau, Y-H Chan, K-H Yiu, S Tam, S-W Li, C-P Lau, and H-F Tse
Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low-intermediate risk
Postgrad. Med. J.,
March 1, 2008;
84(989):
153 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Der, G. Kerekes, K. Veres, P. Szodoray, J. Toth, G. Lakos, G. Szegedi, and P. Soltesz
Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome
Lupus,
July 1, 2007;
16(7):
497 - 503.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Kullo and A. R. Malik
Arterial Ultrasonography and Tonometry as Adjuncts to Cardiovascular Risk Stratification
J. Am. Coll. Cardiol.,
April 3, 2007;
49(13):
1413 - 1426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Akdogan, M. Calguneri, B. Yavuz, E. B. Arslan, U. Kalyoncu, L. Sahiner, O. Karadag, I. Ertenli, S. Kiraz, K. Aytemir, et al.
Are Familial Mediterranean Fever (FMF) Patients at Increased Risk for Atherosclerosis? Impaired Endothelial Function and Increased Intima Media Thickness Are Found in FMF
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2351 - 2353.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Parker, S. J. Ridout, and D. N. Proctor
Age and flow-mediated dilation: a comparison of dilatory responsiveness in the brachial and popliteal arteries
Am J Physiol Heart Circ Physiol,
December 1, 2006;
291(6):
H3043 - H3049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kovacs, J. Toth, J. Tarjan, and A. Koller
Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE
Eur J Heart Fail,
August 1, 2006;
8(5):
451 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Celermajer
Primary and a Half Prevention: Can We Identify Asymptomatic Subjects With High Vascular Risk?
J. Am. Coll. Cardiol.,
June 21, 2005;
45(12):
1994 - 1996.
[Full Text]
[PDF]
|
 |
|
|